1 orgs in this cluster's subtree
Every organization with primary activities in CFC Syndrome Research & Registry or any of its descendants. Click a column header to sort. Filter by name or state above the table.
| # | Organization | State | Revenue | Activities ↓ |
|---|---|---|---|---|
| 1 | CARDIO-FACIO-CUTANEOUS INTERNATIONAL Nonprofit organization supporting individuals and families affected by Cardio-Facio-Cutaneous (CFC) syndrome, a rare genetic disorder. Provides family support,… | AZ | $146K | 16 |
strategies used in this cluster
Theories of action extracted from orgs in this subtree. Click any to see the full set of orgs running the same approach.
- Peer-Based Healing and Support 1 orgBy facilitating connections among veterans through shared experiences, mutual recognition, and peer-led initiatives, the organization fosters psychological healing, social reintegration, and sustained well-being, because shared identity and lived experience create trust, reduce isolation, and reinforce a sense of purpose. This strategy centers on leveraging the unique bond among veterans as a catalyst for emotional, social, and civic recovery. Unlike top-down service models, it relies on peer-driven engagement—through storytelling, camaraderie, mutual aid, and collective advocacy—to build trust and empower individuals. What distinguishes it is the belief that healing and reintegration are not just clinical or transactional outcomes, but relational processes rooted in shared identity and mutual respect.CARDIO-FACIO-CUTANEOUS INTERNATIONAL
- Translational Research Acceleration 1 orgBy bridging scientific discovery and clinical application through integrated research models, organizations accelerate medical innovation and improve patient outcomes, because reducing the gap between lab findings and real-world treatment enables faster, more effective solutions for unmet health needs. This strategy emphasizes a deliberate, structured pathway from basic science to clinical impact, unifying diverse efforts such as genomic analysis, biospecimen sharing, cross-species oncology, and bench-to-bedside collaboration. Unlike general research funding or isolated lab work, this approach prioritizes bidirectional flow between researchers and clinicians, ensuring that discoveries are not only scientifically sound but also clinically actionable. It is distinguished by its focus on process acceleration—via data standardization, pre-competitive collaboration, or rapid translation—rather than discovery alone.CARDIO-FACIO-CUTANEOUS INTERNATIONAL